The Call4Ideas of MIND Education kicks off
The Call 4 Ideas of the MIND Education program, the project that involves young people and students in the co-creation of the City of the Future, kicks off.
Submit your idea by April 29, 2022!
Conceived and promoted by Arexpo and Lendlease together with Human Technopole, IRCCS Galeazzi, Fondazione Triulza, Federated Innovation area Life Sciences & Health Care – with leading companies in the sector such as Accenture, AstraZeneca, Be Whiz, Bio4Dreams, Bracco, Life Science District, Nippon Gases cooperate Italy, Novartis, Stevanato Group, Synlab – the Call 4 Ideas invites recent graduates (who obtained their degree in the year 2021 and 2022), students and doctoral students of Italian universities to develop ideas and project on two fundamental themes of the innovation district:
1. MEANWHILE SOLUTIONS @MIND: the aim is using the “waiting time” – the period between the approval of the Masterplan and its realization – as a tool to mend social tissues and as a strategic resource to design a more sustainable and inclusive future that promotes citizen participation and well-being.
2. Health Data Science: by using digital technologies and Big Data, finding solutions that improve the health and well-being of citizens through the adoption of behaviors and lifestyles that prevent diseases, help their early diagnosis and the sharing of information (data) by the population.
A jury made up of professionals and researchers from the promoters will select the 3 best ideas for each Call that will be awarded with the following prizes:
- 1st prize € 5,000
- 2nd prize € 3,000
- 3rd prize € 2,000
In addition, the winners will have the opportunity to present their project at the final event of MIND education in June 2022.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.